May Measurement Month 2022: results from the global blood pressure screening campaign
Cargando...
Fecha
2024
Autores
Beaney, Thomas
Keziah Kerr, Gabriele
Kiru, Gaia
McArdle, Harsha
Schlaich, Markus
Schutte, Aletta E.
Stergiou, George S.
Ji-guang, Wang
Marin, Marcos J.
Henandez-Hernandez, Rafael
Título de la revista
ISSN de la revista
Título del volumen
Editor
BMJ
Resumen
Introduction Elevated blood pressure (BP) is the major
contributor to mortality and disease burden worldwide.
May Measurement Month (MMM) is a global BP
screening campaign, which aims to raise awareness of
BP measurement and provide evidence to inform and
influence related health policy.
Methods This cross-sectional
survey included individuals
aged≥18 years recruited through opportunistic sampling at
sites in 60 countries during MMM 2022. Each participant
had three sitting BP measurements and a questionnaire
was completed including demographics, comorbidities
and lifestyle factors. Hypertension was defined as a
systolic BP≥140 mm Hg and/or a diastolic BP≥90 mm
Hg (average of the second and third readings) or taking
antihypertensive medication. Multiple imputation was
used to estimate BP readings where any participant’s
BP readings were missing. Linear mixed effects models
were used to identify associations between participant
characteristics and systolic or diastolic BP.
Results Of the 715 518 participants surveyed (excluding
50 200 self-measured
home BP screenees recruited via the
ZOE Health Study app), 257 421 (36.0%) were identified
as hypertensive, of whom 57.6% were aware and 49.3%
were on antihypertensive medication. Of all participants
with hypertension, 26.1% were controlled to <140/90 mm
Hg and 12.0% to <130/80 mm Hg. Of those taking
antihypertensive medication, 52.7% were taking only one
drug class, 52.9% were controlled to <140/90 mm Hg
and 24.4% to 130/80 mm Hg. In total, 190 314 (26.6%
of total surveyed, 73.9% of hypertensives) participants
screened were found to have untreated or inadequately
treated hypertension. Only 27.6% of treated hypertensive
participants were taking a statin. Substantial coexistence
of diabetes, overweight and hypertension was apparent
among participants.
Descripción
Palabras clave
Citación
Beaney T, Kerr GK, Kiru G, et al. May Measurement Month 2022: results from the global blood pressure screening campaign. BMJ Glob Health 2024;9:e016557. doi:10.1136/bmjgh-2024-016557
